Epidemiology of acromegaly: review of population studies

被引:0
作者
Aikaterini Lavrentaki
Alessandro Paluzzi
John A. H. Wass
Niki Karavitaki
机构
[1] National and Kapodistrian University of Athens,Endocrine Unit, ARETAIEION Hospital, Faculty of Medicine
[2] University Hospitals Birmingham NHS Foundation Trust,Department of Neurosurgery
[3] Churchill Hospital,Oxford Centre for Diabetes, Endocrinology and Metabolism
[4] University of Birmingham,Institute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences
[5] Birmingham Health Partners,Centre for Endocrinology, Diabetes and Metabolism
来源
Pituitary | 2017年 / 20卷
关键词
Acromegaly; Epidemiology; Prevalence; Incidence;
D O I
暂无
中图分类号
学科分类号
摘要
Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5–5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.
引用
收藏
页码:4 / 9
页数:5
相关论文
共 114 条
[1]  
Katznelson L(2014)Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 3933-3951
[2]  
Laws ER(2010)Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK) Clin Endocrinol (Oxf) 72 377-382
[3]  
Melmed S(2006)High prevalence of pituitary adenomas: a cross- sectional study in the province of Liege, Belgium J Clin Endocrinol Metab 91 4769-4775
[4]  
Molitch ME(2014)The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011 Eur J Endocrinol 171 519-526
[5]  
Murad MH(2015)The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study Eur J Endocrinol 173 655-664
[6]  
Utz A(2015)The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013 Pituitary 18 803-807
[7]  
Wass JA(2010)Incidence of pituitary adenomas in Northern Finland in 1992–2007 J Clin Endocrinol Metab 95 4268-4275
[8]  
Fernandez A(2016)Acromegaly incidence, prevalence, complications, and long-term prognosis: a nationwide cohort study Eur J Endocrinol 175 1810190-409
[9]  
Karavitaki N(2007)AcroBel–the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects Eur J Endocrinol 157 399-446
[10]  
Wass JAH(2004)Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA) Eur J Endocrinol 151 439-553